On 9th February, 2014, DLF GLOBAL HOSPITALITY LTD (DGHL) a 100% step down subsidiary of DLF Ltd., announced that it has completed the sale of 100% equity stake in Silverlink Resorts Ltd. (SRL) to Aman Resorts Group Ltd. (ARGL). The →
On January 13, 2014, Cadila Pharmaceuticals announced it strategic partnership with NovaSAID AB to develop new treatments for inflammation and pain in conditions such as rheumatoid arthritis. NovaSAID is a company in Karolinska Development’s portfolio. The companies will collaborate around →
On 29th January 2014, National Aluminium Company Limited (NALCO), a Navratna PSU of Ministry of Mines, Govt. of India,announced the results for the 3rd quarter ended December 2013. The registered net profit stood at Rs. 131 crore, up 10% from →
On 1st February 2014, National Aluminium Company Limited (NALCO), A Navratna PSU, announced that its 2nd wind power project at Ludarva in Jaisalmer district of Rajasthan has been commissioned. The plant has a capacity of 47.6 MW. NALCO has successfully →
On February 24 2014, Reliance Infrastructure Limited (RInfra) announced the completion of the Trichy-Karur road in Tamil Nadu, undertaken through its Special Purpose Vehicle (SPV) TK Toll Road Pvt Ltd. This is RInfra’s tenth road project, which has achieved full →
Reliance Jio, a subsidiary of Reliance Industries Limited, announced on 14th February 2014, that it has won the right to use spectrum in 14 key circles across India in the 1800 MHz band. In the recently concluded spectrum auction conducted →
Birla Corporation Limited, the flagship Company of the M P Birla Group and cement major, announced its third quarter’s results on 9th February, 2014. The company had dispatched 18.08 lakh tons of cement against 15.52 lakh tons in the corresponding →
On 21st February 2014, BEML, the only Public Sector to manufacture metro cars in India, announced that it has successfully rolled out its 136th Metro Car. The same will be for the Delhi Metro Rail Corporation Limited (DMRCL), for deployment →
On 25th February 2014, AstraZeneca announced that it’s orphan drug MYALEPT™ (metreleptin for injection) has been approved by the US Food and Drug Administration (FDA). It is an adjunct to diet as replacement therapy for the treatment of complications of →
On 25th February, 2014, Indian drugmaker Ranbaxy Laboratories Ltd stated that it has suspended all shipments of pharmaceutical ingredients produced at the Toansa and Dewas plants. The step was taken to review processes and controls. Following quality concerns, the shipment →
........................................................................ You can create a free account with us to gain access to just released news and press releases about leading companies from across the world. Your free account can provide you with the latest industry and corporate information to help you take quick business decisions. With your free account, you can be amongst the first ones to know of the latest happenings. So Signup now !!.